HL-21(Champion Pharmaceutics)

N/A

Report date: 2024/12/20 17:11:05
NME

Base Information

Drug NameHL-21(Champion Pharmaceutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChampion Pharmaceutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesChampion Pharmaceutics IncShenzhen Third People'S Hospital
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A